The Risk of Metabolic Syndrome in Patients with Rheumatoid Arthritis: A Meta-Analysis of Observational Studies
Open accessThe DOI matches its Crossref record; 67 of the 68 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Observational studies suggest an association between the incidence of rheumatoid arthritis (RA) and the prevalence of metabolic syndrome (MetS). However, the relationship between RA and MetS is controversial and research in this area is currently lacking. OBJECTIVE: The aim of this study was to assess whether the prevalence of MetS was higher in a group of RA patients compared to subjects without RA. DESIGN: A PubMed database search was conducted during April 2013 to identify observational studies of RA and risk of MetS. Reference lists of retrieved articles were also reviewed. Two authors independently extracted information on the study design, the characteristics of the study participants, exposure and outcome assessments, and the method used to control for potential confounding factors. A random-effects model was used for the risk estimates. RESULTS: Our meta-analysis of four cross-sectional controlled studies plus eight case-control studies involving a total of 2283 cases and 4403 controls identified a significant association between RA and risk of MetS, with an overall OR of 1.24 (95% CI, 1.03-1.50). CONCLUSION: This meta-analysis provides further evidence supporting patients with RA have a higher prevalence of MetS than subjects without RA. In addition, the geographic region of the population and the criteria used for MetS diagnosis could influence the association. However, these observations would need to be evaluated using prospective, randomized studies.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures




Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“patients with autoimmune diseases such as rheumatoid arthritis that are characterized by systemic inflammation have insulin resistance, dyslipidemia and hypertension, and that they have higher rates of metabolic syndrome, type 2 diabetes and CVD”
From Chronic inflammation in the etiology of disease across the life span (2019) · cites this paper as [37]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Measuring inconsistency in meta-analyses
Higgins, J. P. T., Thompson, S. G., Deeks, J. J., & Altman, D. G. (2003) · BMJ · doi:10.1136/bmj.327.7414.557 · Cited by 63,139 · cited 1×
“We also calculated the I2 statistic, a quantitative measure of inconsistency across studies [8].”
MethodBias in meta-analysis detected by a simple, graphical test
Egger, M., Smith, G. D., Schneider, M., & Minder, C. (1997) · BMJ · doi:10.1136/bmj.315.7109.629 · Cited by 56,722
Meta-analysis in clinical trials
DerSimonian, R., & Laird, N. (1986) · Controlled Clinical Trials · doi:10.1016/0197-2456(86)90046-2 · Cited by 39,552 · cited 1×
“Results from the random-effects model, which considers both within- and between-study variation [9], were used to compute the summary risk estimate.”
MethodGrundy, S. M., Bilheimer, D. W., Chait, A., Clark, L. T., Denke, M. A., Havel, R. J., Hazzard, W. R., Hulley, S. B., Hunninghake, D. B., Kreisberg, R. A., et al. (1993) · JAMA · doi:10.1001/jama.269.23.3015 · Cited by 27,947
Expert Panel on Detection, E. (2001) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.285.19.2486 · Cited by 26,011
Meta-analysis of Observational Studies in Epidemiology<SUBTITLE>A Proposal for Reporting</SUBTITLE>
Stroup, D. F. (2000) · JAMA · doi:10.1001/jama.283.15.2008 · Cited by 20,623
Operating characteristics of a rank correlation test for publication bias
Begg, C. B., & Mazumdar, M. (1994) · Biometrics · doi:10.2307/2533446 · Cited by 16,955
Alberti, K. G. M. M., Eckel, R. H., Grundy, S. M., Zimmet, P. Z., Cleeman, J. I., Donato, K. A., Fruchart, J.-C., James, W. P. T., Loria, C. M., & Smith, S. C. (2009) · Circulation · doi:10.1161/circulationaha.109.192644 · Cited by 14,860
Diagnosis and Classification of Diabetes Mellitus
American Diabetes Association (2011) · Diabetes Care · doi:10.2337/dc11-s062 · Cited by 13,988
The metabolic syndrome—a new worldwide definition
Alberti, K. G. M., Zimmet, P., & Shaw, J. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67402-8 · Cited by 9,352 · cited 1×
“To date, six definitions for MetS have been established: the Joint Consensus 2009 of the International Diabetes Federation (IDF) Task Force, National Heart, Lung, and Blood Institute, American Heart Association, World Heart Federation, International Atherosclerosis Society and International Association for the Study o…”
Method
Research works printed but not linked: 2
- M Gonzalez-Gay, 2010, Visfatin is not associated with inflammation or metabolic syndrome in patients with severe rheumatoid arthritis undergoing anti-TNF-α therapy, Clin Exp Rheumatol, 28, 56
- M Sahebari, 2011, Investigation of the association between metabolic syndrome and disease activity in rheumatoid arthritis. The Scientific, World J, 11, 1195, 10.1100/tsw.2011.111 · DOI
Cited by
Chronic inflammation in the etiology of disease across the life span
Furman, D., Campisi, J., Verdin, E., Carrera-Bastos, P., Targ, S., Franceschi, C., Ferrucci, L., Gilroy, D. W., Fasano, A., Miller, G. W., et al. (2019) · Nature Medicine · doi:10.1038/s41591-019-0675-0 · Cited by 4,915
Tournadre, A., Vial, G., Capel, F., Soubrier, M., & Boirie, Y. (2019) · Joint Bone Spine · doi:10.1016/j.jbspin.2018.08.001 · Cited by 375
“Both proinflammatory cytokines (IL-6, TNFα) and glucocorticoids promote insulin resistance in RA (20).”
BackgroundAtherosclerosis in rheumatoid arthritis: is it all about inflammation?
Skeoch, S., & Bruce, I. N. (2015) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2015.40 · Cited by 281
Subclinical hypothyroidism and type 2 diabetes: A systematic review and meta-analysis
Han, C., He, X., Xia, X., Li, Y., Shi, X., Shan, Z., & Teng, W. (2015) · PLoS ONE · doi:10.1371/journal.pone.0135233 · Cited by 258
“We computed prevalence according to measurements reported previously [22, 23].”
MethodSelf-citationRheumatoid arthritis and metabolic syndrome
Kerekes, G., Nurmohamed, M. T., González-Gay, M. A., Seres, I., Paragh, G., Kardos, Z., Baráth, Z., Tamási, L., Soltész, P., & Szekanecz, Z. (2014) · Nature Reviews Rheumatology · doi:10.1038/nrrheum.2014.121 · Cited by 215
Cardiovascular disease in inflammatory rheumatic diseases
Castañeda, S., Nurmohamed, M. T., & González-Gay, M. Á. (2016) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2016.10.006 · Cited by 161
Metabolic syndrome, autoimmunity and rheumatic diseases
Medina, G., Lastra, O. L. V., Peralta-Amaro, A. L., Jiménez-Arellano, M. P., Saavedra, M. Á., Cruz-Domínguez, M. P., & Jara, L. J. (2018) · Pharmacological Research · doi:10.1016/j.phrs.2018.01.009 · Cited by 143
Wagenaar, C. A., van de Put, M., Bisschops, M., Walrabenstein, W., de Jonge, C. S., Herrema, H., & van Schaardenburg, D. (2021) · Nutrients · doi:10.3390/nu13093208 · Cited by 131
Atopic dermatitis: pathomechanisms and lessons learned from novel systemic therapeutic options
Bieber, T. R. M., Paller, A. S., Kabashima, K., Feely, M. A., Rueda, M. J., Terres, J. A. R., & Wollenberg, A. (2022) · Journal of the European Academy of Dermatology and Venereology · doi:10.1111/jdv.18225 · Cited by 104
Vickman, R. E., Aaron, L., Zhang, R., Lanman, N. A., Lapin, B. R., Gil, V., Greenberg, M., Sasaki, T., Cresswell, G. M., Broman, M. M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29719-1 · Cited by 93
Hallajzadeh, J., Safiri, S., Mansournia, M. A., Khoramdad, M., Izadi, N., Almasi‐Hashiani, A., Pakzad, R., Ayubi, E., Sullman, M. J. M., & Karamzad, N. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170361 · Cited by 76
Abatacept Improves Whole-Body Insulin Sensitivity in Rheumatoid Arthritis: An Observational Study
Ursini, F., Russo, E., Hribal, M. L., Mauro, D., Savarino, F., Bruno, C., Tripolino, C., Rubino, M., Naty, S., & Grembiale, R. D. (2015) · Medicine · doi:10.1097/md.0000000000000888 · Cited by 70
Potential Benefits of Antioxidant Phytochemicals in Type 2 Diabetes
Arabshomali, A., Bazzazzadehgan, S., Mahdi, F., & Shariat‐Madar, Z. (2023) · Molecules · doi:10.3390/molecules28207209 · Cited by 69
Autoimmune atherosclerosis in 3D: How it develops, how to diagnose and what to do
Szekanecz, Z., Kerekes, G., Végh, E., Kardos, Z., Baráth, Z., Tamási, L., & Shoenfeld, Y. (2016) · Autoimmunity Reviews · doi:10.1016/j.autrev.2016.03.014 · Cited by 58
Ruscitti, P., Cipriani, P., Masedu, F., Romano, S., Berardicurti, O., Liakouli, V., Carubbi, F., Benedetto, P. D., Alvaro, S., Penco, M., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0170108 · Cited by 50
Body mass index and response to tocilizumab in rheumatoid arthritis: a real life study
Gardette, A., Ottaviani, S., Sellam, J., Berenbaum, F., Lioté, F., Meyer, A., Sibilia, J., Fautrel, B., Palazzo, É., & Dieudé, P. (2016) · Clinical Rheumatology · doi:10.1007/s10067-016-3183-3 · Cited by 49
Sun, C., Qin, W., Zhang, Y., Wu, Y., Li, Q., Liu, M., & He, C. (2017) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.13153 · Cited by 47
Self-citationShen, J., Shang, Q., & Tam, L. (2015) · Translational research · doi:10.1016/j.trsl.2015.05.006 · Cited by 43
The metabolic profile in early rheumatoid arthritis: a high prevalence of metabolic obesity
Müller, R., Kull, M. M., Põlluste, K., Aart, A., Eglit, T., Lember, M., & Kallikorm, R. (2016) · Rheumatology International · doi:10.1007/s00296-016-3464-9 · Cited by 33
Parra-Salcedo, F., Contreras-Yáñez, I., Elías-López, D., Aguilar-Salinas, C. A., & Pascual‐Ramos, V. (2015) · Arthritis Research & Therapy · doi:10.1186/s13075-015-0549-x · Cited by 32
“Regarding prevalence of MetS in RA, there have been conflicting results but the most recent meta-analysis of 12 observational, cross-sectional studies involving 2,283 Caucasian and Asian RA patients showed a significantly increased prevalence when compared with 4,403 controls [14].”
BackgroundResultPrevalence of metabolic syndrome in women with rheumatoid arthritis and effective factors.
Bilecik, N. A., Tuna, S., Samancı, N., Balcı, N., & Akbas, H. S. (2014) · Europe PMC (PubMed Central) · Cited by 30
Cardiac Impairment in Rheumatoid Arthritis and Influence of Anti-TNFα Treatment
Lazúrová, I., & Tomáš, Ľ. (2016) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-016-8566-3 · Cited by 28
Gomes, K. W. P., Luz, A. J. P., Felipe, M. R. D. B., Beltrão, L. A., Sampaio, A. X. C., & Rodrigues, C. E. M. (2018) · Modern Rheumatology · doi:10.1080/14397595.2017.1316813 · Cited by 26
“and 4403 controls revealed a positive correlation [12].”
BackgroundRuscitti, P., Margiotta, D. P. E., Macaluso, F., Iacono, D., Donofrıo, F., Emmi, G., Atzeni, F., Prete, M., Perosa, F., Sarzi‐Puttini, P., et al. (2017) · Medicine · doi:10.1097/md.0000000000008180 · Cited by 33
“To date, multiple lines evidence con fi rmed a signi fi cant association between RA and MS, T2D and HBP. [28,29] Furthermore, in this context, meta-analytic data con fi rmed the role of traditional CV risk factors in accelerating atherosclerosis thus CVEs, in RA patients.”
BackgroundLuo, P., Wanli, X., Ye, D., Chen, W., Ying, J., Liu, B., Li, J., Sun, X., He, Z., Wen, C., et al. (2024) · The Journal of Rheumatology · doi:10.3899/jrheum.2023-0349 · Cited by 27
Unmet needs in the management of cardiovascular risk in inflammatory joint diseases
Castañeda, S., Vicente‐Rabaneda, E. F., García-Castañeda, N., Prieto-Pena, D., Dessein, P. H., & González-Gay, M. Á. (2019) · Expert Review of Clinical Immunology · doi:10.1080/1744666x.2019.1699058 · Cited by 25
“patients with IJD [2], particularly in those with PsA [58,59].”
BackgroundMetabolic abnormalities in patients with inflammatory rheumatic diseases
Dessein, P. H., Solomon, A., & Hollan, I. (2016) · Best Practice & Research Clinical Rheumatology · doi:10.1016/j.berh.2016.10.001 · Cited by 25
Sex and Cardiovascular Involvement in Inflammatory Joint Diseases
Castañeda, S., González‐Juanatey, C., & González-Gay, M. Á. (2017) · Clinical Reviews in Allergy & Immunology · doi:10.1007/s12016-017-8635-2 · Cited by 24
Rheumatoid arthritis, cardiometabolic comorbidities, and related conditions: need to take action
Corrao, S., Calvo, L., Giardina, A. R., Cangemi, I., Falcone, F., & Argano, C. (2024) · Frontiers in Medicine · doi:10.3389/fmed.2024.1421328 · Cited by 29
Prevention of Stroke in Rheumatoid Arthritis
Zha, A. M., Napoli, M. D., & Behrouz, R. (2015) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-015-0600-y · Cited by 25
Managing cardiovascular risk in patients with inflammatory arthritis: practical considerations
Tournadre, A., Mathieu, S., & Soubrier, M. (2016) · Therapeutic Advances in Musculoskeletal Disease · doi:10.1177/1759720x16664306 · Cited by 24
Burggraaf, B., der Stoep, D. F. V. B.-V., de Vries, M. A., Klop, B., van Zeben, J., van de Geijn, G. M., van der Meulen, N., Birnie, E., Prinzen, L., & Cabezas, M. C. (2018) · Atherosclerosis · doi:10.1016/j.atherosclerosis.2018.02.019 · Cited by 21
Verstappen, S. M. M., Askling, J., Berglind, N., Franzén, S., Frisell, T., Garwood, C., Greenberg, J. D., Holmqvist, M. E., Horne, L., Lampl, K. L., et al. (2015) · Arthritis Care & Research · doi:10.1002/acr.22661 · Cited by 20
Bhattacharya, P. K., Barman, B., Jamil, M., & Bora, K. (2020) · Journal of Translational Internal Medicine · doi:10.2478/jtim-2020-0015 · Cited by 24
Cardiovascular Consequences of Autoimmune Rheumatic Diseases
Atzeni, F., Nucera, V., Gerratana, E., Fiorenza, A., Gianturco, L., Corda, M., & Sarzi‐Puttini, P. (2020) · Current Vascular Pharmacology · doi:10.2174/1570161118666200127142936 · Cited by 21
Relationship between Metabolic Syndrome and Rheumatoid Arthritis
Lee, S., Choi, H.-C., Cho, B., An, A.-R., Seo, Y., Jin, H.-S., Oh, S.-M., & Jang, S. H. (2016) · Korean Journal of Family Medicine · doi:10.4082/kjfm.2016.37.1.44 · Cited by 21
Kumar, A., Vasdev, V., Manrai, M., Bhayana, A., Hegde, A., Arjun, M., & Kishore, K. (2018) · Indian Journal of Rheumatology · doi:10.4103/injr.injr_92_18 · Cited by 17
“[36] Since the present study has excluded the patients with metabolic syndrome, the inference of our study may not be extrapolated to patients with RA and coexisting metabolic syndrome.”
Prevalence and contributing factors of metabolic syndrome in rheumatoid arthritis patients
Bagheri‐Hosseinabadi, Z., Moadab, F., & Abbasifard, M. (2024) · BMC Endocrine Disorders · doi:10.1186/s12902-024-01675-5 · Cited by 17
Vial, G., Coudy‐Gandilhon, C., Pinel, A., Wauquier, F., Chevenet, C., Béchet, D., Wittrant, Y., Coxam, V., Soubrier, M., Tournadre, A., et al. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2019.158574 · Cited by 16
Metabolic syndrome in rheumatoid arthritis patients: Relationship among its clinical components
García‐Chagollán, M., Hernández‐Martínez, S. E., Rojas‐Romero, A. E., Muñóz-Valle, J. F., Sigala‐Arellano, R., Cerpa‐Cruz, S., Morales‐Núñez, J. J., Lomelí-Nieto, J. Á., Ojeda, G. M., & Hernández‐Bello, J. (2020) · Journal of Clinical Laboratory Analysis · doi:10.1002/jcla.23666 · Cited by 15
Metabolic syndrome is associated with disease activity in patients with rheumatoid arthritis
Tantayakom, P., Koolvisoot, A., Arromdee, E., Chiowchanwisawakit, P., Muangchan, C., & Katchamart, W. (2016) · Joint Bone Spine · doi:10.1016/j.jbspin.2015.10.016 · Cited by 14
Rongen, G. A. P. J. M., van Ingen, I. L., Kok, M. R., Vonkeman, H. E., Janssen, M., & Jansen, T. (2018) · Clinical Rheumatology · doi:10.1007/s10067-017-3961-6 · Cited by 13
“Patients with RA are more likely to have obesity, insulin resistance, hyperlipidaemia and hypertension, important risk factors for atherosclerosis [2, 3].”
BackgroundAssociation of Leptin Levels and Disease Activity in Patients with Early Rheumatoid Arthritis
Taylan, A., Akıncı, B., Toprak, B., Bırlık, M., Arslan, F. D., Ekerbiçer, H. Ç., Gündoğdu, B., Çolak, A., & Engin, B. (2021) · Archives of Medical Research · doi:10.1016/j.arcmed.2021.02.002 · Cited by 13
Oliveira, M. C., Tavares, L. P., Vago, J. P., Batista, N. V., Queiroz‐Junior, C. M., Vieira, A. T., Menezes, G. B., Sousa, L. P., van de Loo, F. A. J., Teixeira, M. M., et al. (2016) · PLoS ONE · doi:10.1371/journal.pone.0146403 · Cited by 12
“The metabolic syndrome is a risk factor for patients with rheumatoid arthritis (RA) [1] and the cause of this dysfunction is still unclear.”
BackgroundDamen, M. S. M. A., Ballak, D. B., Sapinsley, Z., Bai, X., Chan, E. D., Seals, D. R., Popa, C. D., & Joosten, L. A. B. (2019) · Cytokine · doi:10.1016/j.cyto.2019.154793 · Cited by 12
The impact of metabolic syndrome on rheumatoid arthritis in a cohort of Egyptian patients
Eldin, A. B., Bakry, S. A. E., Morad, C. S., & Abd-El-Samie, A. M. (2017) · The Egyptian Rheumatologist · doi:10.1016/j.ejr.2017.09.005 · Cited by 11
Sağlam, B., Kaymaz‐Tahra, S., Kenar, G., Kocaer, S. B., Omma, A., Erden, A., Kara, M., Yazici, A., Çefle, A., Gerçik, Ö., et al. (2022) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.14335 · Cited by 9
Xu, H., Choi, S., Kang, J.-K., Park, D.-J., Lee, J.-K., & Lee, S. (2020) · Joint Bone Spine · doi:10.1016/j.jbspin.2020.03.015 · Cited by 10
Fu, L., Zhang, J., Jin, L., Zhang, Y., Cui, S., & Chen, M. (2017) · Modern Rheumatology · doi:10.1080/14397595.2017.1307711 · Cited by 8
“that AO would be a risk factor for developing RA [44].”
BackgroundSelf-citationTournadre, A., Vial, G., Capel, F., Soubrier, M., & Boirie, Y. (2018) · Revue du Rhumatisme · doi:10.1016/j.rhum.2018.06.003 · Cited by 7
Rheumatoid arthritis and metabolic syndrome
de Assis, M. R., & Serafim, P. A. (2016) · Revista Brasileira de Reumatologia (English Edition) · doi:10.1016/j.rbre.2016.02.015 · Cited by 6
Prevalence of Steatotic Liver Disease Among US Adults with Rheumatoid Arthritis
Vassilopoulos, A., Kalligeros, M., Vassilopoulos, S., Shehadeh, F., Benitez, G., Kaczynski, M., Lazaridou, I., Promrat, K., Wands, J. R., & Mylonakis, E. E. (2024) · Digestive Diseases and Sciences · doi:10.1007/s10620-023-08225-4 · Cited by 9
Kong, C., Wang, C.-L., Niu, K., & Qi, W. (2021) · International Journal of Rheumatic Diseases · doi:10.1111/1756-185x.14148 · Cited by 5
Letchumanan, G., & Say, Y. (2025) · International Journal of Immunogenetics · doi:10.1111/iji.70018 · Cited by 4
“Indeed, patients with autoimmune diseases, like rheumatoid arthritis (RA) and psoriasis (Ps) were also found in association with but not limited to metabolic diseases, diabetes mellitus, ischaemic heart disease and stroke (Armstrong et al. 2013; Dregan et al. 2014; Zhang et al. 2013).”
Parasitic infection as a potential therapeutic tool against rheumatoid arthritis
Apaer, S., Tuxun, T., Ma, H.-Z., Zhang, H., Aierken, A., Aini, A., Li, Y., Lin, R., & Wen, H. (2016) · Experimental and Therapeutic Medicine · doi:10.3892/etm.2016.3660 · Cited by 5
Self-citationMetabolic syndrome in a cohort of rheumatoid arthritis patients
Ciobanu, D. A., Bărbulescu, A. L., Traşcǎ, B. A., Pârvănescu, C. D., Firulescu, S. C., Dinescu, Ș. C., Biță, C. E., Crînguş, L.-I., Tica, A. A., & Vreju, F. A. (2022) · Romanian Journal of Rheumatology · doi:10.37897/rjr.2022.3.7 · Cited by 3
“Similar prevalence was reported by Zhang et al., in a meta-analysis that included 12 observational studies involving 2,283 RA cases [14], or Karvounaris SA et al. [15].”
High prevalence of undiagnosed impaired glucose tolerance in patients with rheumatoid arthritis
Warman, N. ‘. E., Baharuddin, H., Rahman, T. H. A., Ismail, N. B., Ch’ng, S. S., Rosman, A., & Ghani, R. A. (2022) · SAGE Open Medicine · doi:10.1177/20503121221088088 · Cited by 3
Weiß, K., Schmidt, W., Krause, A., & Schäfer, V. S. (2022) · Applied Sciences · doi:10.3390/app12020851 · Cited by 2
Circulating leptin and resistin levels in a Romanian rheumatoid arthritis population
Petra, C. V., Vonica, C. L., Răhăian, R., Berceanu, I., Vesa, Ș. C., Zdrenghea, M., & Rednic, S. (2020) · Romanian Journal of Rheumatology · doi:10.37897/rjr.2020.2.6 · Cited by 2
INFLAMMATION-LOWERING EFFECTS OF ORAL ANTIDIABETIC DRUGS IN RHEUMATOID ARTHRITIS
Roman, I., Negru, M. M., Berghea, F., Duna, M., Stoian, C., Predețeanu, D., & Ionescu, R. M. (2017) · Romanian Journal of Rheumatology · doi:10.37897/rjr.2017.1.4 · Cited by 1
Ali, M. A. M., Abdelkareem, M. I., Doma, M., & Ibrahim, A. M. (2020) · The Egyptian Journal of Hospital Medicine · doi:10.21608/ejhm.2020.108885 · Cited by 1
“Rheumatoid arthritis and metabolic syndrome are considered diseases with common traits that can increase the risk of cardiovascular disease (5) with previous research showing an association between the two ((6)).”
BackgroundInfluentialTurgunova, L., Shalygina, A. A., Ibrayeva, L., & Turmuhambetova, A. (2021) · Open Access Macedonian Journal of Medical Sciences · doi:10.3889/oamjms.2021.5943 · Cited by 1
“have been shown that in patients with RA, the prevalence of MetS is higher than in patients without RA [9].”
BackgroundPreclinical atherosclerosis in rheumatoid arthritis
O’Sullivan, M. (2014) · Arrow@dit (Dublin Institute of Technology) · Cited by 1
Mechanisms of vascular protection in chronic inflammatory disease
Thornton, C. C. (2014) · Spiral (Imperial College London) · doi:10.25560/26595
Síndrome metabólico en artritis reumatoide
la Cruz, A. P. D.-D., Flores-Chávez, A., Hernández-Cuervo, P., Romero-Moreno, J. R., Félix-Hernández, F., Aguilar-Ríos, E. G., Rodríguez-Hernández, T. M., & González-López, L. (2014)
Kenawy, E. M. (2016) · Journal of Medical Science And clinical Research · doi:10.18535/jmscr/v4i10.42
Tantayakom, P., Koolvisoot, A., Arromdee, E., Chiowchanwisawakit, P., Muangchan, C., & Katchamart, W. (2017) · Revue du Rhumatisme · doi:10.1016/j.rhum.2017.05.006
Ikdahl, E. (2017) · NVA (Nasjonalt vitenarkiv)
A artrite reumatoide e a síndrome metabólica
de Assis, M. R., & Serafim, P. A. (2016) · Revista Brasileira de Reumatologia · doi:10.1016/j.rbr.2016.02.001
Luz, A. J. P., Andrade, R. P. O. M., Vieira, W. P., Studart, S., & Vieira, R. M. R. D. A. (2017) · Revista Brasileira de Reumatologia · doi:10.1016/j.rbr.2017.06.056
Ausência de influência da síndrome metabólica na atividade da artrite reumatóide
Farinazo, B. M., Real, M. M. F., & Caldas, C. A. M. (2017) · Pará Research Medical Journal · doi:10.4322/prmj.2017.032
Nieman, D. C. (2020) · Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature · doi:10.3410/f.737032981.793575943
Roubille, C. (2023) · La Revue de Médecine Interne · doi:10.1016/j.revmed.2023.11.001
Hanscom, D. A., Halaris, A. E., & Erb, M. (2024) · Elsevier eBooks · doi:10.1016/b978-0-12-816996-4.00009-5
Vicencio, Y. A., Barrera, J. P. G., Alvarado, D. A., Vargas, E. E. A., & Guillen, E. T. (2025) · Estudios y Perspectivas Revista Científica y Académica · doi:10.61384/r.c.a..v5i4.1587
Impact des comorbidités sur l’évolution des maladies chroniques
Roubille, C. (2021) · theses.fr (ABES) · doi:10.70675/fa780adcz6d00z43b6zacd5z4db2eec52d15
Tarjányi, V., Szilágyi, A., Szekeres, R., Takács, B., Varga, B., Priksz, D., Gesztelyi, R., Viczján, G., Erdei, T., Görögh, P., et al. (2026) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2026.119772
Yin, Z., Zhang, Y., Sun, Z., Yang, Y., Ouédraogo, S. Y., Golubnitschaja, O., Grech, G., & Zhan, X. (2026) · Advances in predictive, preventive and personalised medicine · doi:10.1007/978-3-032-32838-0_2
Self-citationCuț, D., Deaconu, L., Popescu, S. D., & Sorescu, T. (2026) · IntechOpen eBooks · doi:10.5772/intechopen.1018208
Monterrosas‐Brisson, N., Jiménez‐Ferrer, E., González‐Cortazar, M., Beltrán-Salazar, V., Zapata-Lopera, Y. M., Maruri, D. T., Flores‐Franco, G., & Herrera-Ruiz, M. L. (2026) · Current Issues in Molecular Biology · doi:10.3390/cimb48111094
Metadata
- Authors
- Zhang, J., Fu, L., Shi, J., Chen, X., Li, Y., Ma, B., & Zhang, Y.
- Affiliations
- First Hospital of China Medical University (CN)
- China Medical University (CN)
- Corresponding author
- Fu, Lingyu
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2013-10-25
- Volume
- 8
- Issue
- 10
- Pages
- e78151
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC3808281
- OpenAlex
- W2003877413
- Cited by
- 81
- References
- 68
- Citations by year
- 2026: 4 · 2025: 2 · 2024: 5 · 2023: 2 · 2022: 6 · 2021: 5 · 2020: 7 · 2019: 4 · 2018: 6 · 2017: 13 · 2016: 14 · 2015: 7 · 2014: 6
- FWCI
- 1.43
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, other-oa)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Funders
- National Natural Science Foundation of China (30800944, 30671796)
- Topics
- Health Sciences › Medicine › Rheumatology › Rheumatoid Arthritis Research and Therapies
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes, Cardiovascular Risks, and Lipoproteins
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Keywords
- rheumatoid arthritis, metabolic syndrome, prevalence, risk factors, regional variation, confounding
- MeSH terms
- Arthritis, Rheumatoid, Cross-Sectional Studies, Humans, Prevalence, Metabolic Syndrome
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.